The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 6 results:
Author Title [ Type(Desc)] Year
Filters: Author is Andreadis, Dimitrios  [Clear All Filters]
Journal Article
Bakopoulou, A., Kritis A., Andreadis D., Papachristou E., Leyhausen G., Koidis P., et al. (2015).  Angiogenic Potential and Secretome of Human Apical Papilla Mesenchymal Stem Cells in Various Stress Microenvironments.. Stem Cells Dev. 24(21), 2496-512.
Andreadis, D., Pavlou A. - Maria, Vakirlis E., Anagnostou E., Vrani F., Poulopoulos A., et al. (2020).  Daylight photodynamic therapy for the management of actinic cheilitis.. Arch Dermatol Res. 312(10), 731-737.
Xenikakis, I., Tzimtzimis M., Tsongas K., Andreadis D., Demiri E., Tzetzis D., et al. (2019).  Fabrication and finite element analysis of stereolithographic 3D printed microneedles for transdermal delivery of model dyes across human skin in vitro.. Eur J Pharm Sci. 137, 104976.
Andreadis, D., Angelopoulos I., Aggelidou E., Gousopoulou E., Volk J., Poulopoulos A., et al. (2023).  Minor salivary gland stem cells: a comparative study of the biological properties under clinical-grade culture conditions.. Cell Tissue Res.
Bourlidou, E., Vahtsevanos K., Kyrgidis A., Tilaveridis I., Patsatsi A., Andreadis D., et al. (2019).  Risk factors for local recurrence of basal cell carcinoma and cutaneous squamous cell carcinoma of the middle third of the face: a 15-year retrospective analysis based on a single centre.. Eur J Dermatol. 29(5), 490-499.
Karamini, A., Bakopoulou A., Andreadis D., Gkiouras K., & Kritis A. (2020).  Therapeutic Potential of Mesenchymal Stromal Stem Cells in Rheumatoid Arthritis: a Systematic Review of In Vivo Studies.. Stem Cell Rev Rep. 16(2), 276-287.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.